GL1X · GenesisL1 explorer

Ligand · NRO

NRO · 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid

NRO, 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid (C16 H15 N O5, 301.3 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most…

Component
NRO
Formula
C16 H15 N O5
Class
ligand
Structures
4
PDB entries
2

Binding sites

NRO in 4 structures; the first of them:

  • 2ZK5 · Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed… · NRO A1 · binds LYS263, PHE264, ILE267, ILE281, GLY284, CYS285, ARG288, SER289 and 9 more
  • 3ADX · Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233 · NRO A1 · binds LEU255, PHE264, ILE267, ILE281, CYS285, ARG288, SER289, ILE326 and 8 more
  • 2ZK5 · Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed… · NRO A1 · binds LYS263, PHE264, ILE267, ILE281, GLY284, CYS285, ARG288, SER289 and 9 more
  • 3ADX · Human ppargamma ligand-binding domain in complex with indomethacin and nitro-233 · NRO A1 · binds LEU255, PHE264, ILE267, ILE281, CYS285, ARG288, SER289, ILE326 and 8 more

Residues it binds most

ILE 6, LEU 6, MET 6, SER 6, PHE 6, ARG 6, CYS 6, VAL 6, ALA 2, GLY 2 (residue and the binding sites it lines).

Found with

  • IMN · Indomethacin

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.